|

CP-506 Clinical Trials

1 actively recruiting trial

Also known as: HAP CP-506

Pipeline

Phase 1/2: 1

Top Sponsors

  • Maastricht University Medical Center1

Indications

  • Unspecified Adult Solid Tumor, Protocol Specific1
  • Breast Cancer1
  • Cancer1

Other1 trial

Phase 1/2 Clinical Trial of CP-506 (HAP) in Monotherapy or With Carboplatin or ICI
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.